Das K M, Valenzuela I, Williams S E, Soeiro R, Kadish A S, Baum S G
Gastroenterology. 1983 Feb;84(2):364-74.
Following injection of Crohn's disease tissue filtrates, lymphomas and hyperplastic lymph nodes developed in 16% of athymic nude (nu/nu) mice; whereas only 4% of control nude mice developed lymphadenopathy (p less than 0.025). One hundred forty coded sera from 111 patients (Crohn's disease = 36, ulcerative colitis = 28, diarrheal and other controls = 47) were assayed by indirect immunofluorescence for immunoreactivity with the lymphomas and hyperplastic lymph nodes. Coded sections were examined by two observers and scored on a 0 to 3 + scale. Fifty-four percent of the sera from patients with Crohn's disease were reactive with the Crohn's disease induced lymphoma by this assay. Eighty percent of sera from patients with symptomatic Crohn's disease were positive, whereas 22% of sera from patients in remission were positive. Sixty-six percent of sera from patients with symptomatic Crohn's disease reacted against hyperplastic lymph nodes induced by Crohn's disease filtrates. In contrast, only one control serum (from a patient with ulcerative colitis) reacted with the lymphomas or hyperplastic lymph nodes. Lymphomas induced by other means or arising spontaneously did not show immunofluorescence with Crohn's disease or control sera. Electron microscopy revealed C-type viral particles in five lymphomas induced by Crohn's disease filtrates and in one control lymphoma, but not in five hyperplastic lymph nodes and five control lymph nodes. Absorption of Crohn's disease sera with control lymphoma or with murine leukemia virus infected fibroblasts did not diminish immunoreactivity, whereas similar absorption with lymphomas induced by Crohn's disease filtrates abolished the immunofluorescence. These studies indicate that Crohn's disease tissue, when injected into athymic nude mice, induces lymphoid hyperplasia and lymphomas that contain an antigen(s) recognized by Crohn's disease sera.
注射克罗恩病组织滤液后,16%的无胸腺裸鼠(nu/nu)发生了淋巴瘤和淋巴结增生;而对照裸鼠中只有4%出现了淋巴结病(p<0.025)。对来自111例患者(克罗恩病=36例,溃疡性结肠炎=28例,腹泻及其他对照=47例)的140份编码血清进行间接免疫荧光检测,以检测其与淋巴瘤和增生淋巴结的免疫反应性。两名观察者对编码切片进行检查,并按0至3+分级评分。通过该检测,54%的克罗恩病患者血清与克罗恩病诱导的淋巴瘤发生反应。有症状的克罗恩病患者血清中80%呈阳性,而缓解期患者血清中22%呈阳性。66%有症状的克罗恩病患者血清与克罗恩病滤液诱导的增生淋巴结发生反应。相比之下,只有一份对照血清(来自一名溃疡性结肠炎患者)与淋巴瘤或增生淋巴结发生反应。其他方式诱导或自发产生的淋巴瘤与克罗恩病血清或对照血清均未显示免疫荧光。电子显微镜检查发现,在5例由克罗恩病滤液诱导的淋巴瘤和1例对照淋巴瘤中发现了C型病毒颗粒,但在5个增生淋巴结和5个对照淋巴结中未发现。用对照淋巴瘤或感染鼠白血病病毒的成纤维细胞吸收克罗恩病血清不会降低免疫反应性,而用克罗恩病滤液诱导的淋巴瘤进行类似吸收则会消除免疫荧光。这些研究表明,将克罗恩病组织注射到无胸腺裸鼠体内时,会诱导淋巴样增生和淋巴瘤,这些淋巴瘤含有一种能被克罗恩病血清识别的抗原。